Unleashing the full potential of Real-World Evidence

Clinical Research meets Europe's leading medical practice-software network. One integrated ecosystem for real-world data - from feasibility to publication.

Talk to Experts
Strategic Partnership

The RWE ecosystem built on the network that already sees your patients

Alcedis and CGM MARE unite 30+ years of clinical research & longitudinal EHR data from 6,500+ office-based physicians and 21 million patient records. Exclusive access to one of the largest structured real-world patient datasets globally. Faster cohorts. Cleaner data. Evidence you can act on.

 

Real-world evidence — faster, leaner, built on real patient data

RWE is no longer optional. Yet classical post-authorization studies take years and cost millions. Alcedis and CGM MARE combine CRO capabilities with EHR access across Germany, Austria, France, and the US — so sponsors get first analysis results in six months, saving 10x costs of a classical NIS.

Already delivering for global sponsors

Pilot projects with AstraZeneca (InspeCKD case study), Bayer (Fine-Real case study), and Lilly (tirzepatide publication) have validated the approach across cardiology, nephrology, and metabolic research. InspeCKD alone analyzed 800,000+ patient datasets and was covered in 80+ articles. In our joint webinar, Philipp Thiele (CompuGroup Medical) and the Alcedis RWE team discuss how EHR data is transforming early detection and treatment of chronic diseases.

Secondary Data Analysis

Clinical insights from longitudinal EHR data — in months, not years.

Accelerated Recruitment

Find the right patients and sites before your study begins.

EHR2EDC Integration

Structured patient data, straight from EHR into the study eCRF.

Cross-indication insights from 21M+ patient records

  • Real-world uptake of launched therapies
  • Undiagnosed disease populations and care gaps
  • Screening and diagnostic in routine care
  • Treatment patterns and guideline adherence
  • Drug safety, effectiveness, and health-economic outcomes

Find the right patients and sites before study start

  • Pre-study feasibility against real EHR data
  • Evidence-based site selection
  • Automated patient pre-screening
  • Direct patient referral to the closest study site
  • Continuous recruitment monitoring

Data flows once — from source to study

  • Automated transfer of structured EHR data into the Alcedis Platforms™ eCRF — powered by the joint infrastructure
  • Fewer transcription errors and higher data quality 
  • Full GCP-compliant audit trail
  • Less documentation burden for sites
  • Combined retrospective and prospective data 

Optimizing drug development with Real-World Evidence

Our expert speakers guide you through the nuances of leveraging RWE, its role in the adoption of new treatments and its critical impact in the InspeCKD study, which analyzed approximately 450,000 anonymized patient records from 1,250 general practices in Germany. We discuss the tangible benefits of RWE, moving beyond theory to real-world application, and address the technical integration challenges encountered along the way.

 

Rewatch Webinar

Ready to generate real-world evidence at scale?

Let's talk about your indication, your cohort, and your timelines.

Talk to our RWE team